Skip to content
Peptide Spencer
Partner

Reproductive & melanocortin

PT-141

  • 10 mg

Custom strengths on request

FDA-approved as Vyleesi (bremelanotide). Compounded PT-141 is not FDA-approved. Source, Nov 13, 2025

At a glance

These dosages are a helpful guide, not a prescription. Every clinician is expected to do their own due diligence before prescribing.

  1. Start

    1.75 mg subcutaneously per dose, abdomen or thigh, as needed

    Approved label

  2. Ceiling

    1.75 mg SC per dose, no titration; over 8 doses per month not recommended

    Approved label
Frequency
As needed, at least 45 min before activity; no more than one dose in 24 hours
Route
Subcutaneous, abdomen or thigh (autoinjector)
Course
Discontinue after 8 weeks if no improvement in symptoms
Contraindicated in uncontrolled hypertension or known cardiovascular disease; approved only for premenopausal women, and male trials used intranasal doses that do not convert to subcutaneous.
Calculate this dose

Full dosing guide

Get a quote

Custom strengths on request. Prices are quoted per clinic.